Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
Steroid |
| gptkbp:abusePotential |
High
|
| gptkbp:administeredBy |
gptkb:Oral
gptkb:Injection |
| gptkbp:affects |
gptkb:Skeletal_muscle
Bone density Red blood cell production Secondary sexual characteristics |
| gptkbp:bannedIn |
gptkb:International_Olympic_Committee
gptkb:World_Anti-Doping_Agency |
| gptkbp:cause |
High blood pressure
Addiction Cholesterol imbalance Hormonal imbalance Increased risk of prostate cancer Mood swings Psychiatric effects Stunted growth in adolescents Suppression of natural testosterone production |
| gptkbp:chemicalClass |
Anabolic agent
Androgen |
| gptkbp:detects |
Blood test
Urine test |
| gptkbp:discoveredIn |
1930s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anabolic steroids
|
| gptkbp:legalStatus |
Controlled substance in many countries
|
| gptkbp:marketedAs |
Bodybuilding supplement
Performance-enhancing drug |
| gptkbp:metabolism |
Liver
|
| gptkbp:misuse |
Common among adolescents
Common in bodybuilding Common in sports |
| gptkbp:regulates |
Prescription required in many countries
|
| gptkbp:relatedTo |
gptkb:Testosterone
|
| gptkbp:sideEffect |
gptkb:cardiovascular_disease
Aggression Acne Hair loss Infertility Gynecomastia Liver damage Testicular atrophy Virilization in women |
| gptkbp:usedFor |
Performance enhancement
Muscle growth Treatment of delayed puberty Treatment of muscle wasting diseases |
| gptkbp:bfsParent |
gptkb:Schedule_III
|
| gptkbp:bfsLayer |
6
|